Artikel ; Online: trans
Dalton transactions (Cambridge, England : 2003)
2024 Band 53, Heft 12, Seite(n) 5616–5623
Abstract: The chemokine receptor CXCR4 is implicated in multiple diseases including inflammatory disorders, cancer growth and metastasis, and HIV/AIDS. CXCR4 targeting has been evaluated in treating cancer metastasis and therapy resistance. Cyclam derivatives, ... ...
Abstract | The chemokine receptor CXCR4 is implicated in multiple diseases including inflammatory disorders, cancer growth and metastasis, and HIV/AIDS. CXCR4 targeting has been evaluated in treating cancer metastasis and therapy resistance. Cyclam derivatives, most notably AMD3100 (Plerixafor™), are a common motif in small molecule CXCR4 antagonists. However, AMD3100 has not been shown to be effective in cancer treatment as an individual agent. Configurational restriction and transition metal complex formation increases receptor binding affinity and residence time. In the present study, we have synthesized novel |
---|---|
Mesh-Begriff(e) | Benzylamines ; Coordination Complexes/pharmacology ; Cyclams ; Heterocyclic Compounds/pharmacology ; Heterocyclic Compounds/chemistry ; Receptors, CXCR4/antagonists & inhibitors |
Chemische Substanzen | Benzylamines ; Coordination Complexes ; cyclam (295-37-4) ; Cyclams ; Heterocyclic Compounds ; plerixafor (S915P5499N) ; Receptors, CXCR4 |
Sprache | Englisch |
Erscheinungsdatum | 2024-03-19 |
Erscheinungsland | England |
Dokumenttyp | Journal Article |
ZDB-ID | 1472887-4 |
ISSN | 1477-9234 ; 1364-5447 ; 0300-9246 ; 1477-9226 |
ISSN (online) | 1477-9234 ; 1364-5447 |
ISSN | 0300-9246 ; 1477-9226 |
DOI | 10.1039/d3dt01729j |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.